Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Urology|May 20, 2008
Urinary retention and post-void residual urine in men: separating truth from traditionSteven A Kaplan, Alan J Wein, David R Staskin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 13, 2009
Extended-release trospium chloride improves quality of life in overactive bladderRoger R Dmochowski, Matt T Rosenberg, Norm R Zinner, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|September 4, 2009
Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndromePeter K Sand, Roger R Dmochowski, Norman R Zinner, et al.
The Journal of Urology|April 25, 2008
Nicotinic signaling ameliorates acute bladder inflammation induced by protamine sulfate or cyclophosphamideJonathan S Starkman, Magaly Martinez-Ferrer, Juan M Iturregui, et al.
The Journal of Urology|July 12, 2005
A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trialsAnnabel Nixon, Shoshana Colman, Luann Sabounjian, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 30, 2017
Botulinum toxin to treat pelvic painYingchun Zhang, Christopher P Smith
The Journal of Urology|January 22, 2008
The evolution of obstruction induced overactive bladder symptoms following urethrolysis for female bladder outlet obstructionJonathan S Starkman, John W Duffy, Christopher E Wolter, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|August 3, 2007
Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulationJonathan S Starkman, John W Duffy, Christopher E Wolter, et al.
Neurourology and Urodynamics|April 5, 2011
Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptomsNorman R Zinner, Roger R Dmochowski, David R Staskin, et al.
Drugs & Aging|March 7, 2012
Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladderMichael B Chancellor, David R Staskin, Gary G Kay, et al.
Pageof 13